PolyNovo Limited
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for her… Read more
PolyNovo Limited (CALZF) - Total Assets
Latest total assets as of June 2025: $127.41 Million USD
Based on the latest financial reports, PolyNovo Limited (CALZF) holds total assets worth $127.41 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
PolyNovo Limited - Total Assets Trend (1999–2025)
This chart illustrates how PolyNovo Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
PolyNovo Limited - Asset Composition Analysis
Current Asset Composition (June 2025)
PolyNovo Limited's total assets of $127.41 Million consist of 60.5% current assets and 39.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 26.3% |
| Accounts Receivable | $24.39 Million | 19.1% |
| Inventory | $14.49 Million | 11.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $661.00K | 0.5% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1999–2025)
This chart illustrates how PolyNovo Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PolyNovo Limited's current assets represent 60.5% of total assets in 2025, a decrease from 78.7% in 1999.
- Cash Position: Cash and equivalents constituted 26.3% of total assets in 2025, down from 76.7% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 21.0% in 1999.
- Asset Diversification: The largest asset category is accounts receivable at 19.1% of total assets.
PolyNovo Limited Competitors by Total Assets
Key competitors of PolyNovo Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
PolyNovo Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - PolyNovo Limited generates 1.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, PolyNovo Limited generates $ 10.37 in net profit.
PolyNovo Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.77 | 3.41 | 2.03 |
| Quick Ratio | 2.25 | 3.03 | 1.91 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $49.22 Million | $ 56.05 Million | $ 9.80 Million |
PolyNovo Limited - Advanced Valuation Insights
This section examines the relationship between PolyNovo Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.20 |
| Latest Market Cap to Assets Ratio | 2.89 |
| Asset Growth Rate (YoY) | 17.2% |
| Total Assets | $127.41 Million |
| Market Capitalization | $368.65 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values PolyNovo Limited's assets at a significant premium ( 2.89x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: PolyNovo Limited's assets grew by 17.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for PolyNovo Limited (1999–2025)
The table below shows the annual total assets of PolyNovo Limited from 1999 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $127.41 Million | +17.19% |
| 2024-06-30 | $108.72 Million | +17.38% |
| 2023-06-30 | $92.62 Million | +164.85% |
| 2022-06-30 | $34.97 Million | -8.78% |
| 2021-06-30 | $38.34 Million | +1.27% |
| 2020-06-30 | $37.86 Million | +34.11% |
| 2019-06-30 | $28.23 Million | -5.34% |
| 2018-06-30 | $29.82 Million | +147.36% |
| 2017-06-30 | $12.06 Million | -24.77% |
| 2016-06-30 | $16.02 Million | +97.21% |
| 2015-06-30 | $8.13 Million | -13.68% |
| 2014-06-30 | $9.41 Million | +9.22% |
| 2013-06-30 | $8.62 Million | -3.26% |
| 2012-06-30 | $8.91 Million | -24.32% |
| 2011-06-30 | $11.77 Million | -21.64% |
| 2010-06-30 | $15.02 Million | -13.11% |
| 2009-06-30 | $17.29 Million | +0.73% |
| 2008-06-30 | $17.16 Million | -22.05% |
| 2007-06-30 | $22.02 Million | -11.75% |
| 2006-06-30 | $24.95 Million | +33.51% |
| 2005-06-30 | $18.69 Million | +0.19% |
| 2004-06-30 | $18.65 Million | +149.53% |
| 2003-06-30 | $7.47 Million | -40.75% |
| 2002-06-30 | $12.61 Million | +74.65% |
| 2001-06-30 | $7.22 Million | -39.62% |
| 2000-06-30 | $11.96 Million | +69.01% |
| 1999-06-30 | $7.08 Million | -- |